Search

Abstract: Blood glucose measurements are important components of a effective diabetes management. Self-monitoring of blood glucose (SMBG) provides the possibility for collecting information on glucose levels at different timepoints and facilitates patient empowerment. However, the efficacy of SMBG in particular groups of patients is controversial. Self-monitoring is postulated to have a beneficial effect on metabolic control in type 1 diabetes as it is essential to adjust insulin doses. In type 2 diabetes the efficacy of frequent glucose measurements remains uncertain. The purpose of this paper is to overview recent data in the field of self-control to evaluate the influence of SMBG on glycaemic control in type 2 diabetes. The results of studies suggest that SMBG can have an important role in improving metabolic control if it is an integral part of a wider educational strategy. SMBG can be especially recommended for type 2 diabetic patients with suboptimal metabolic control in order to promote dietary and lifestyle changes as well as treatment correction as a response to feedback provided by blood glucose results. [Copyright &y& Elsevier]

Diabetes mellitus has the negative influence on life expectancy. Most effective efforts to reverse this tendency are focused on outpatient intervention. However, treatment during hospitalizations due to coexisting diseases plays also important role. In the review the maintenance algorithms during hospitalization at intensive care unit as well as at acute myocardial infarction were presented and discussed. Currently available data suggest that intravenous insulin infusion to achieve normoglycemia and standard monitoring are most effective. After hospital discharge aggressive hypoglycemic treatment is mandatory to improve prognosis wile the drug choice seem to play the secondary role. [ABSTRACT FROM AUTHOR]

Abstract: Diabetes mellitus has the negative influence on life expectancy. Most effective efforts to reverse this tendency are focused on outpatient intervention. However, treatment during hospitalizations due to coexisting diseases plays also important role. In the review the maintenance algorithms during hospitalization at intensive care unit as well as at acute myocardial infarction were presented and discussed. Currently available data suggest that intravenous insulin infusion to achieve normoglycemia and standard monitoring are most effective. After hospital discharge aggressive hypoglycemic treatment is mandatory to improve prognosis wile the drug choice seem to play the secondary role. [Copyright &y& Elsevier]

Abstract: Type 2 diabetic (T2D) patients are particularly prone to macrovascular complications. Coronary heart disease is two to four times more frequent in T2D patients compared with non-diabetic individuals. Patients with diabetes mellitus who underwent acute MI have unfavourable prognosis. Diabetes and Insulin–Glucose Infusion in Acute MI study (DIGAMI) has shown that metabolic control by means of insulin–glucose i.v. infusion in the acute phase of MI followed by long-term intensive insulin therapy improves prognosis in the T2D patients. The DIGAMI-2 study did not confirm conclusions of DIGAMI 1 study. The authors of this article comment on the results of DIGAMI 2 and attempt to answer how T2D patients should be treated after MI. [Copyright &y& Elsevier]